PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

76 hedge funds and large institutions have $68.8M invested in Paratek Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 29 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+4
Holders Change %
+5.56%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
19
Reduced
29
Closed
8
Calls
$108K
Puts
$17K
Net Calls
+$91K
Net Calls Change
-$161K

Top Buyers

1
AWA
Arete Wealth Advisors
Illinois
$26.3M
2
Millennium Management
Millennium Management
New York
$1.06M
3
ACM
AIGH Capital Management
Maryland
$7.77M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
$459K
5
Citadel Advisors
Citadel Advisors
Florida
$380K

Top Sellers

1
1CM
1492 Capital Management
Wisconsin
$0
2
JGC
J. Goldman & Co
New York
$94.2K
3
Two Sigma Investments
Two Sigma Investments
New York
$36.2K
4
Simplex Trading
Simplex Trading
Illinois
$29K
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$245K
Name Holding Trade Value Shares
Change 		Shares
Change %
HI
76
Harbour Investments
Wisconsin
$4 – – –
1CM
77
1492 Capital Management
Wisconsin
– -$1.29M -501,050 Closed
HCM
78
Highbridge Capital Management
New York
– -$108K -42,154 Closed
LP
79
LMR Partners
United Kingdom
– -$45K -17,469 Closed
Walleye Capital
80
Walleye Capital
New York
– -$31K -12,000 Closed
PFS
81
Prospera Financial Services
Texas
– -$29K -11,465 Closed
TRCT
82
Tower Research Capital (TRC)
New York
– -$10K -3,768 Closed
CUAMC
83
China Universal Asset Management Company
China
– -$1K -514 Closed
1 2 3
4